Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 7 (2010), Issue 12 (December)

1. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.
   Am J Clin Oncol, 33(6): 599-603. [Abstract] [Full-text]
2. Basics of particle therapy II biologic and dosimetric aspects of clinical hadron therapy.
   Am J Clin Oncol, 33(6): 646-9. [Abstract] [Full-text]
3. Potential of helical tomotherapy to reduce dose to the ocular structures for patients treated for unresectable sinonasal cancer.
   Am J Clin Oncol, 33(6): 595-8. [Abstract] [Full-text]
4. Effectiveness of three-dimensional conformal radiotherapy for treating early primary nasopharyngeal carcinoma.
   Am J Clin Oncol, 33(6): 604-8. [Abstract] [Full-text]
5. A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.
   Am J Clin Oncol, 33(6): 619-23. [Abstract] [Full-text]
6. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?
   Am J Clin Oncol, 33(6): 633-6. [Abstract] [Full-text]
7. Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1).
   Am J Clin Oncol, 33(6): 577-82. [Abstract] [Full-text]
8. CyberKnife radiosurgery for the treatment of intraocular and periocular lymphoma.
   Arch Ophthalmol, 128(12): 1561-7. [Abstract] [Full-text]
9. Effect of high-dose total body irradiation on ACTH, corticosterone, and catecholamines in the rat.
   Transl Res, 157(1): 38-47. [Abstract] [Full-text]
10. Dynamics of delayed p53 mutations in mice given whole-body irradiation at 8 weeks.
    Int J Radiat Oncol Biol Phys, 79(1): 247-54. [Abstract] [Full-text]
11. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
    Int J Radiat Oncol Biol Phys, 79(1): 262-8. [Abstract] [Full-text]
12. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 279-88. [Abstract] [Full-text]
13. Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery.
    Int J Radiat Oncol Biol Phys, 79(1): 305-11. [Abstract] [Full-text]
14. Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 312-20. [Abstract] [Full-text]
15. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes.
    Int J Radiat Oncol Biol Phys, 79(1): 121-9. [Abstract] [Full-text]
16. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
    Int J Radiat Oncol Biol Phys, 79(1): 52-9. [Abstract] [Full-text]
17. Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers.
    Int J Radiat Oncol Biol Phys, 79(1): 158-62. [Abstract] [Full-text]
18. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 137-42. [Abstract] [Full-text]
19. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.
    Int J Radiat Oncol Biol Phys, 79(1): 65-70. [Abstract] [Full-text]
20. Primary radiation therapy for head-and-neck cancer in the setting of human immunodeficiency virus.
    Int J Radiat Oncol Biol Phys, 79(1): 60-4. [Abstract] [Full-text]
21. Dosimetric comparison of intensity-modulated stereotactic radiotherapy with other stereotactic techniques for locally recurrent nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys, 79(1): 71-9. [Abstract] [Full-text]
22. Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 105-9. [Abstract] [Full-text]
23. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 80-8. [Abstract] [Full-text]
24. Improvements in critical dosimetric endpoints using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation: preliminary dosimetric findings of a phase iv trial.
    Int J Radiat Oncol Biol Phys, 79(1): 26-33. [Abstract] [Full-text]
25. Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy--an Australian analysis.
    Int J Radiat Oncol Biol Phys, 79(1): 179-87. [Abstract] [Full-text]
26. A comparison of skin and chest wall dose delivered with multicatheter, Contura multilumen balloon, and MammoSite breast brachytherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 34-8. [Abstract] [Full-text]
27. Effect of high-dose total body irradiation on ACTH, corticosterone, and catecholamines in the rat.
    Transl Res, 157(1): 38-47. [Abstract] [Full-text]
28. Lack of a correlation between γH2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer.
    Int J Radiat Biol, 87(1): 46-56. [Abstract] [Full-text]
29. Genetic background and lymphocyte populations after total-body exposure to iron ion radiation.
    Int J Radiat Biol, 87(1): 8-23. [Abstract] [Full-text]
30. Dynamics of delayed p53 mutations in mice given whole-body irradiation at 8 weeks.
    Int J Radiat Oncol Biol Phys, 79(1): 247-54. [Abstract] [Full-text]
31. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
    Int J Radiat Oncol Biol Phys, 79(1): 262-8. [Abstract] [Full-text]
32. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 279-88. [Abstract] [Full-text]
33. Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery.
    Int J Radiat Oncol Biol Phys, 79(1): 305-11. [Abstract] [Full-text]
34. Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 312-20. [Abstract] [Full-text]
35. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes.
    Int J Radiat Oncol Biol Phys, 79(1): 121-9. [Abstract] [Full-text]
36. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
    Int J Radiat Oncol Biol Phys, 79(1): 52-9. [Abstract] [Full-text]
37. Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers.
    Int J Radiat Oncol Biol Phys, 79(1): 158-62. [Abstract] [Full-text]
38. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 137-42. [Abstract] [Full-text]
39. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.
    Int J Radiat Oncol Biol Phys, 79(1): 65-70. [Abstract] [Full-text]
40. Primary radiation therapy for head-and-neck cancer in the setting of human immunodeficiency virus.
    Int J Radiat Oncol Biol Phys, 79(1): 60-4. [Abstract] [Full-text]
41. Dosimetric comparison of intensity-modulated stereotactic radiotherapy with other stereotactic techniques for locally recurrent nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys, 79(1): 71-9. [Abstract] [Full-text]
42. Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 105-9. [Abstract] [Full-text]
43. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 80-8. [Abstract] [Full-text]
44. Improvements in critical dosimetric endpoints using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation: preliminary dosimetric findings of a phase iv trial.
    Int J Radiat Oncol Biol Phys, 79(1): 26-33. [Abstract] [Full-text]
45. Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy--an Australian analysis.
    Int J Radiat Oncol Biol Phys, 79(1): 179-87. [Abstract] [Full-text]
46. A comparison of skin and chest wall dose delivered with multicatheter, Contura multilumen balloon, and MammoSite breast brachytherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 34-8. [Abstract] [Full-text]
47. Effect of high-dose total body irradiation on ACTH, corticosterone, and catecholamines in the rat.
    Transl Res, 157(1): 38-47. [Abstract] [Full-text]
48. Lack of a correlation between γH2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer.
    Int J Radiat Biol, 87(1): 46-56. [Abstract] [Full-text]
49. Genetic background and lymphocyte populations after total-body exposure to iron ion radiation.
    Int J Radiat Biol, 87(1): 8-23. [Abstract] [Full-text]
50. Dynamics of delayed p53 mutations in mice given whole-body irradiation at 8 weeks.
    Int J Radiat Oncol Biol Phys, 79(1): 247-54. [Abstract] [Full-text]
51. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
    Int J Radiat Oncol Biol Phys, 79(1): 262-8. [Abstract] [Full-text]
52. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 279-88. [Abstract] [Full-text]
53. Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery.
    Int J Radiat Oncol Biol Phys, 79(1): 305-11. [Abstract] [Full-text]
54. Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 312-20. [Abstract] [Full-text]
55. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes.
    Int J Radiat Oncol Biol Phys, 79(1): 121-9. [Abstract] [Full-text]
56. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
    Int J Radiat Oncol Biol Phys, 79(1): 52-9. [Abstract] [Full-text]
57. Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers.
    Int J Radiat Oncol Biol Phys, 79(1): 158-62. [Abstract] [Full-text]
58. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 137-42. [Abstract] [Full-text]
59. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.
    Int J Radiat Oncol Biol Phys, 79(1): 65-70. [Abstract] [Full-text]
60. Primary radiation therapy for head-and-neck cancer in the setting of human immunodeficiency virus.
    Int J Radiat Oncol Biol Phys, 79(1): 60-4. [Abstract] [Full-text]
61. Dosimetric comparison of intensity-modulated stereotactic radiotherapy with other stereotactic techniques for locally recurrent nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys, 79(1): 71-9. [Abstract] [Full-text]
62. Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 105-9. [Abstract] [Full-text]
63. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.
    Int J Radiat Oncol Biol Phys, 79(1): 80-8. [Abstract] [Full-text]
64. Improvements in critical dosimetric endpoints using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation: preliminary dosimetric findings of a phase iv trial.
    Int J Radiat Oncol Biol Phys, 79(1): 26-33. [Abstract] [Full-text]
65. Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy--an Australian analysis.
    Int J Radiat Oncol Biol Phys, 79(1): 179-87. [Abstract] [Full-text]
66. A comparison of skin and chest wall dose delivered with multicatheter, Contura multilumen balloon, and MammoSite breast brachytherapy.
    Int J Radiat Oncol Biol Phys, 79(1): 34-8. [Abstract] [Full-text]
67. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia.
    Pediatr Blood Cancer, 56(2): 279-81. [Abstract] [Full-text]
68. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia.
    Pediatr Blood Cancer, 56(2): 279-81. [Abstract] [Full-text]
69. Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.
    Br J Radiol, 84(997): 58-63. [Abstract] [Full-text]
70. Feasibility of safe ultra-high (EQD(2)>100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by Helical Tomotheraphy.
    Acta Oncol, 50(1): 25-34. [Abstract] [Full-text]
71. Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage.
    Acta Oncol, 50(1): 42-50. [Abstract] [Full-text]
72. Set-up errors analyses in IMRT treatments for nasopharyngeal carcinoma to evaluate time trends, PTV and PRV margins.
    Acta Oncol, 50(1): 61-71. [Abstract] [Full-text]
73. Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologies.
    Acta Oncol, 50(1): 72-80. [Abstract] [Full-text]
74. Response of arteriovenous malformations to gamma knife therapy evaluated with pulsed arterial spin-labeling MRI perfusion.
    AJR Am J Roentgenol, 196(1): 15-22. [Abstract] [Full-text]
75. Initial treatment costs of organ-confined prostate cancer: a general perspective.
    BJU Int, 107(1): 1-3. [Abstract] [Full-text]
76. What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility?
    Laryngoscope, 121(1): 116-34. [Abstract] [Full-text]
77. What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility?
    Laryngoscope, 121(1): 116-34. [Abstract] [Full-text]

© 2004-2012 Radiotherapy Research Today. All Rights Reserved.